The Australian medical landscape is abuzz with the arrival of retatrutide, a novel dual GIP and GLP-1 medication showing significant results in scientific trials for treating obesity. This medication https://businessbookmark.com/story7361597/retatrutide-australia-australia-a-new-prospect-for-weight-management